IMPORTANT SAFETY INFORMATION FOR PATIENTS BEING TREATED FOR ASTHMA: Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, the active ingredient in SEREVENT® DISKUS®, increase the risk of asthma-related death. (See Boxed Warning.) CONTINUED BELOW
We could not find the page you requested. Use one of the links above to return to the site.